|
業務類別
|
-- |
|
業務概覽
|
Grand Pharmaceutical Group Ltd, is an international pharmaceutical company of technological innovation. Its core businesses cover three areas: nuclear medicine anti-tumor diagnosis and treatment, cerebro-cardiovascular precision interventional diagnosis and treatment technology, pharmaceutical technology, and biotechnology. Based on the pharmaceutical and biological industries, the Group focuses on the needs of patients, and technological innovation as the driving force Geographically, it derives a majority of its revenue from the PRC and also has a presence in America; Europe; and Asia other than the PRC, and others. |
| 公司地址
| 99 Queen's Road Central, Units 3302, 33rd Floor, The Center, Hong Kong, HKG |
| 電話號碼
| -- |
| 傳真號碼
| -- |
| 公司網頁
| https://www.grandpharm.com |
| 員工數量
| 12614 |
| Mr. Chao Zhou |
Director and Chief Executive Officer |
-- |
29/04/2026 |
|
|
| Mr. Chao Zhou |
Director and Chief Executive Officer |
29/04/2026 |
| Ms. Tosi Wan Winnie So |
Independent Director |
29/04/2026 |
| Mr. Yebi Hu |
Independent Director |
29/04/2026 |
| Dr. Geng Pei, PhD |
Independent Director |
29/04/2026 |
| Dr. Weikun Tang |
Executive Chairman of the Board |
29/04/2026 |
| Mr. Guang Yang |
Director |
29/04/2026 |
| Ms. Chit Yee Jessica Lam |
Director |
29/04/2026 |
| Dr. Li Na Xing |
Independent Director |
29/04/2026 |
|
|
|
|
